Sleep Specialists Celebrates 15 Years, Unveils Zzoma+ Sensor, Launches Clinical Trial, Focuses on Value-Based Care

10 Jun, 2015, 10:30 ET

BALA CYNWYD, Pa., June 10, 2015 /PRNewswire/ — Sleep Specialists, LLC, a medical device company specializing in sleep therapy, announced today that their FDA cleared Zzoma Positional Device was used in a clinical trial examining the cost effectiveness of incorporating positional therapy into the treatment algorithm for obstructive sleep apnea (OSA).  The results were presented at the 29th Annual Meeting of the Associated Professional Sleep Societies in Seattle Washington.

The new study was conducted out of Temple University in Philadelphia and included patients from the Law Enforcement Health Benefits (LEHB) organization.  Following a screening questionnaire used to identify patients at high risk for OSA, 54 of 59 patients (91%) were found to have OSA on their home sleep test.  With 24% of the patients having positional OSA, and utilizing the Zzoma Positional Device as their treatment modality resulted in a 21% cost savings as compared to if all patient were treated with continuous positive airway pressure (CPAP) therapy.   Conclusion: Incorporating positional therapy into the treatment algorithm for OSA is cost effective.

Positional sleep apnea is prevalent in patients with obstructive sleep apnea and treatment may be as simple as preventing “on-the-back” sleeping. Zzoma is a device worn around the upper torso that keeps patients asleep on their sides by preventing supine or “on-the-back” sleeping. Clinicians may prescribe Zzoma as a first line therapy or as an alternative for patients who cannot tolerate oral appliances or Continuous Positive Airway Pressure (CPAP) therapy. A study in the Journal of Clinical Sleep Medicine found that Zzoma was equivalent to CPAP therapy in treating patients with positional OSA. Zzoma is used in the treatment of OSA across the U.S, Australia, Ireland, Finland, England, Spain, Denmark, and other countries.

“Zzoma is an affordable and comfortable device compared to CPAP,” says Sila Yesilsoy, COO of Sleep Specialists, LLC. “The new study only solidified what we already knew: incorporating positional devices into sleep apnea treatment algorithms are highly cost effective.” 

About Sleep Specialists, LLC

Sleep Specialists, LLC ( is a medical device company that specializes in sleep therapy. Our team of board-certified physicians designed the Zzoma®, an FDA-cleared Class II (prescription only) medical device for the treatment of sleep apnea. The company is headquartered in Bala Cynwyd, Pennsylvania, and works with various distributors.

SOURCE Sleep Specialists, LLC